Executive Summary
Across the 18 filings in the India Sector Consolidation Tracker (period 14 Oct 2026), the dominant theme is restructuring and capital reallocation rather than large horizontal M&A: two demergers/schemes (Brooks Laboratories into Abridge Speciality, and GE Power India's power-boiler business into JSW Energy) dominate in materiality, while the remainder are predominantly intra-group capital infusions, small minority stakes, and asset or plant purchases.
Several filings are closer to small-cap promoter-linked or related-party transactions (Sharvaya Metals, Highway Infrastructure, Algoquant) where governance and valuation scrutiny matter more than deal scale. The enriched period-over-period fields are thin in this batch: most target entities are pre-operational (nil turnover at AQCSPL, Highway's target, Agganga, GARL), so growth and margin comparisons cannot be drawn for the newer vehicles, and the more informative data points come from established targets such as HFCL (turnover up 19.3% YoY but still roughly 11% above FY2023-24) and Inexture (FY2026 turnover Rs 1,902.88 lakh against net worth Rs 195.17 lakh). Forward-looking catalysts are concentrated in the second half of FY2027, with DRC's Skizzle acquisition targeted by 31 March 2027, the Vietnam subsidiary of INDO-MIM tentatively incorporated 1 December 2026, and the Bajaj Healthcare/Genrx and GE Power/JSW effective dates still pending. Insider and capital-allocation signals are limited, with the strongest governance flags being the related-party nature of several deals and a data inconsistency in Highway Infrastructure's target share count.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A · Insolvency
Tracking the trend? Catch up on the prior India Sector Consolidation Regulatory Filings digest from October 13, 2026.
Investment Signals (10)
- Laurus Labs / KRKA Pharma ↓ (BULLISH)▲
Rs 107.8 Cr rights-issue subscription at unchanged 49% stake, taking total holding to 262.15 mn shares; signals continued commitment to a joint venture with KRKA d.d.
- Kronox Lab Sciences ↓ (BULLISH)▲
All-cash Dahej SEZ plant acquisition (~5,000 sq m) from Axiom Chemicals funded through internal accruals, non-related-party, completion indicated within one month; accretive capacity addition without leverage
- Hindustan Oil Exploration (HOEC) (BULLISH)▲
Took over Hollong Modular Gas Processing Plant operations from Expro North Sea on 14 Oct 2026 with all plant staff transferred; positions HOEC to add capacity for three newly approved wells and future Dirok additions
- Maithan Alloys / HFCL ↓ (BULLISH)▲
Bought 780,000 HFCL shares (0.05%) for Rs 20.00 Cr; HFCL's FY2025-26 turnover rose 19.3% to Rs 4,528 Cr with PAT of Rs 253 Cr, recovering the prior-year decline
- DRC Systems India ↓ (BULLISH)▲
Exiting a 49.18% associate stake in Inexture Solutions for up to Rs 1.02 Cr while buying 49% of Skizzle Technolabs for up to Rs 2 Cr; capital recycling into a new associate at a cost below the disposal value
- Brooks Laboratories ↓ (BULLISH)▲
Demerger of a business generating Rs 8,287.26 lakh (96.66% of FY2025-26 turnover) into Abridge Speciality on a 1:1 share entitlement; shareholders receive a direct claim on the manufacturing franchise, though the value case depends on listing outcome
- GE Power India / JSW Energy ↓ (BULLISH)▲
NCLT Mumbai sanctioned the demerger of the Durgapur power-boiler and coal-mill business into JSW Energy at 10 JSW shares per 139 GE Power shares; accretive for JSW's thermal equipment capabilities with effective date still pending
- Sharvaya Metals ↓ (BEARISH)▲
Acquisition of Success Electronics via non-cash share swap (Rs 30.24 Cr) plus Rs 11.68 Cr warrant issue at Rs 144 per share; Success reportedly has zero bank debt, but a small revenue base relative to consideration implies a steep valuation
- Highway Infrastructure ↓ (BEARISH)▲
Rs 49.82 Cr promoter-group warrant issue at Rs 49.82 with only 25% upfront, plus a related-party acquisition of 51% of a nil-turnover target; capital raised is large relative to the target's economics
- Algoquant Fintech ↓ (BEARISH)▲
Rs 52.5 lakh rights-issue infusion into a pre-operational 75%-held subsidiary still awaiting SEBI RTA registration and with nil turnover across three years; capital is tied up with no revenue visibility
Risk Flags (9)
- Brooks Laboratories / Demerger Execution↓ [HIGH RISK]▼
Demerged undertaking is ~96.66% of FY2025-26 turnover, leaving the listed retained entity with minimal operating business; scheme requires SEBI, exchange and NCLT approvals with listing expected in ~16 months, and the filing carries no assurance on timing or benefits
- Highway Infrastructure / Data Integrity↓ [HIGH RISK]▼
Target's stated paid-up capital (Rs 5,00,000 = 50,000 shares of Rs 10) does not reconcile with the 25,500 shares implied by 51%; combined with related-party sellers including director relatives, this warrants verification before acquisition approval
- Sharvaya Metals / Related Party Valuation↓ [HIGH RISK]▼
Share-swap acquisition of Success Electronics is a related party deal with promoter Shreyans Katariya and director Balasaheb Kale holding roles in Success; price of Rs 144 per share for a small-revenue target creates minority-shareholder dilution and valuation-fairness risk
- Bajaj Healthcare / Genrx Acquisition↓ [MEDIUM RISK]▼
Acquisition of Genrx Pharmaceuticals (in liquidation) via NCLT order, with no consideration, valuation or financials disclosed, and trading window closed for designated persons; limited information for investors to assess the deal
- Algoquant Fintech / Pre-operational Capital Lock-up↓ [MEDIUM RISK]▼
Subsidiary AQCSPL incorporated Nov 2024, nil turnover for FY2026 and three prior years, and still awaiting SEBI registration; continued parent infusions raise the question of how long capital remains idle
- Exhicon Events / Undisclosed Consideration↓ [MEDIUM RISK]▼
Helicopter purchase (Bell 206 L4, VT-ZIN) by UHPL from Dhillon Aviation with consideration and financial impact undisclosed, and completion dependent on DGCA formalities; asset-heavy charter expansion without visible unit economics
- Turtlemint / Subsidiary Funding Dependence↓ [MEDIUM RISK]▼
Rs 149.51 Cr rights-issue infusion into TIB to fund working capital including lease payments indicates the insurance-broking subsidiary requires parent funding; no completion period specified and two Company executives sit on TIB's board
- GE Power India / Open Timing↓ [MEDIUM RISK]▼
Effective and record dates for the JSW demerger remain unannounced, and the appointed date (01.07.2025) precedes sanction by over a year, so accounting and per-share entitlement could be recast on implementation
- Maithan Alloys / Disclosure Lag↓ [MEDIUM RISK]▼
Trade executed 13 Oct 2026 at 3:30 PM but company became aware of particulars only on 14 Oct 2026 at 09:14 AM; the timing gap raises questions about internal controls over insider and material-event monitoring
Opportunities (9)
- HOEC / Dirok Capacity Expansion (OPPORTUNITY)◆
Operational control of the Hollong gas processing plant enables processing of three newly approved wells plus North and Greater Dirok additions; the expansion is in a PSC with OIL and IOCL, offering volume-driven upside
- JSW Energy / GE Power Demerger↓ (OPPORTUNITY)◆
Sanctioned demerger adds power-boiler, pressure-vessel and coal-mill capabilities to JSW Energy's thermal portfolio; the scheme's share-exchange ratio (10 per 139) creates a clear entitlement pathway once record date is declared
- Brooks Laboratories / Dual-Listing Value Unlock↓ (OPPORTUNITY)◆
Demerger separates a contract-manufacturing and export franchise (Baddi facility, P2P CMO, loan-licensing) from a small trading business; the 1:1 entitlement gives shareholders an immediate claim on the higher-value operating arm once listed
- DRC Systems / Skizzle Associate Build-out↓ (OPPORTUNITY)◆
Acquisition of 49% of Skizzle for up to Rs 2 Cr, combined with the Inexture exit at up to Rs 1.02 Cr, streamlines the portfolio into a single fresh associate with a completion target of 31 March 2027
- Kronox Lab / Dahej SEZ Footprint↓ (OPPORTUNITY)◆
Cash acquisition of a ~5,000 sq m SEZ plant within a month, with no share dilution, adds manufacturing footprint in a chemicals cluster with well-defined regulatory pathway (SEZ Development Commissioner, GIDC, SPCB)
- Laurus Labs / KRKA Joint Venture↓ (OPPORTUNITY)◆
Continued rights-issue participation at constant 49% keeps Laurus aligned with KRKA d.d., Slovenia, a partner with European generics reach; repeat infusions signal commitment to the JV's growth plan
- GMR Airports / Real Estate Adjacency↓ (OPPORTUNITY)◆
Newly incorporated GMR Aero Realty (Rs 1 Cr capital, wholly owned) positions the group to monetise airport-adjacent land and real estate; no timeline yet, but the structure is clean and non-related-party
- INDO-MIM / Vietnam Manufacturing Platform↓ (OPPORTUNITY)◆
Rs 45 Cr five-year investment in a 100%-owned Vietnam single-member LLC for electronics and engineering components, tentatively incorporated 1 Dec 2026 subject to RBI ODI approval; supports a China-plus-one supply-chain positioning
- Turtlemint / Insurance Broking Scale-up↓ (OPPORTUNITY)◆
Rs 149.51 Cr capital infusion into IRDAI-regulated TIB, fully parent-owned and in line with IPO objects, supports a broker platform expansion without change of control
Sector Themes (6)
- Demerger-led Portfolio Reshaping◆
Two of the 18 filings (Brooks Laboratories, GE Power India/JSW Energy) are scheme-of-arrangement demergers, both with listing or effective dates pending NCLT and exchange steps; the pattern shows Indian promoters and strategic acquirers using NCLT schemes to isolate businesses and transfer them to listed or to-be-listed vehicles [IMPLICATION: expect more such schemes, with execution timing as the key variable]
- Intra-group Capital Infusions Dominate the Flow◆
At least 5 filings (Algoquant/AQCSPL, Turtlemint/TIB, United Foodbrands/UFBL UK, GMR/GARL, Laurus/KRKA) are subscriptions into existing or newly formed subsidiaries or JVs, not acquisitions of third-party businesses; this signals that much of the disclosed 'M&A' is capital deployment rather than consolidation, and the consolidation signal should be read with caution [IMPLICATION: distinguish true consolidation from balance-sheet movements when building sector concentration metrics]
- Related-Party and Promoter-Linked Small-cap Deals◆
Sharvaya Metals, Highway Infrastructure and Algoquant involve promoter, director or relative interests, with the target businesses small or nil-turnover; these deals carry governance and valuation risk that sit outside the large-cap consolidation narrative [IMPLICATION: apply heightened scrutiny to related-party share swaps and promoter warrant issues in small-cap filings]
- Nil-turnover Targets Proliferate◆
Target or newly incorporated entities in Highway (nil FY25 and FY26), Agganga (nil turnover FY26), AQCSPL (nil for three years) and GARL (not commenced) show a large share of the batch is pre-revenue vehicles; period-over-period growth is undefined for these, so valuation rests on strategy rather than earnings [IMPLICATION: treat pre-operational entity investments as option-value bets with long, uncertain payback]
- Cash-funded, Non-dilutive Asset Acquisitions◆
Kronox (Dahej plant), Exhicon (helicopter), Minda/Agganga (26% stake), and Maithan/HFCL (market purchase) are cash-funded and largely non-dilutive, with the majority disclosed under Regulation 30 thresholds; this favours balance-sheet-strong acquirers and suggests limited near-term equity overhang [IMPLICATION: cash-funded deals with clear regulatory completion paths are lower-risk than share-swap structures]
- Energy and Power Adjacencies◆
Agganga (solar PV), GE Power/JSW (thermal boilers and coal mills), HOEC (gas processing) and Exhicon's aviation fleet indicate capital flowing into energy-linked and infrastructure-adjacent assets; this is consistent with India's energy-transition and thermal-equipment demand, though the solar exposure is at a very early stage [IMPLICATION: track energy-sector consolidation as a potentially larger theme in subsequent batches]
Watch List (8)
-
NCLT sanction dated 1 Oct 2026 received by both parties; Effective Date and Record Date to be announced, which will set the 10:139 share entitlement timeline [date to be announced]
- Brooks Laboratories Scheme👁
SEBI, exchange and NCLT approvals pending for the demerger into Abridge Speciality; listing targeted in about 16 months, with the Share Entitlement Ratio and renaming (to Xuri Lifesciences) to be finalised [approx. 16 months]
- Highway Infrastructure EGM and Warrant Pricing👁
Shareholder approval needed for Rs 49.82 Cr warrant issue and 51% acquisition; relevant date 14 Oct 2026, and the share-count inconsistency should be resolved before the EGM [EGM date to be announced]
- Sharvaya Metals EGM / Warrant Allotment👁
EGM to approve share swap and 8.11 lakh warrants at Rs 144; 18-month exercise window from allotment will set dilution timing [EGM date to be announced]
-
Vietnam LLC tentatively incorporated 1 Dec 2026 subject to RBI ODI approval; re-appointments of three independent directors (effective 30 Mar 2027) subject to postal ballot [1 Dec 2026 and postal ballot date TBA]
-
Agreement to sign on or before 26 Oct 2026, with Inexture stake sale completing within 60 days; Skizzle acquisition targeted by 31 Mar 2027 [26 Oct 2026; 31 Mar 2027]
-
NCLT order of 13 Oct 2026 effective until further orders; watch for disclosure of consideration and financials once wholly owned subsidiary status is implemented, with trading window closed [date to be announced]
- HOEC Dirok Expansion👁
Post-takeover capacity additions for the three newly approved Dirok wells and North/Greater Dirok volumes; watch for quarterly commentary on throughput and cost savings from ENS exit [next quarterly results]
Filing Analyses
(18)
14-10-2026
Sharvaya Metals Limited's board approved the acquisition of 100% of Success Electronics Private Limited through a non-cash share swap valued at about INR 30,24,00,000 (INR 30.24 Crore), settled by issuing 21,00,000 preferential equity shares to promoter-category sellers at INR 144 per share. The board also approved a preferential issue of 8,11,000 fully convertible warrants at INR 144 each, aggregating INR 11,67,84,000 (INR 11.68 Crore), an increase in authorised share capital, and convening of an Extraordinary General Meeting. The acquisition is a related party transaction, and Success is reported to have a small revenue base relative to the consideration.
- · Acquisition is a related party transaction; promoter Shreyans Ravindra Katariya and director Balasaheb Jalinder Kale hold roles in Success, with valuation by independent registered valuers
- · Success Electronics is reported to carry zero bank debt
- · Warrants carry an 18-month exercise window from allotment, each convertible into one equity share of INR 10 face value
- · Consolidated results of Success will be included in Sharvaya's financials upon completion; Success would become a wholly owned subsidiary
- · Share swap ratio is 21 Sharvaya shares for every 2 Success shares, and the structure is designed to preserve cash resources while increasing equity share capital
- · Relevant Date for the preferential issue is October 07, 2026; approvals remain subject to shareholders and regulatory authorities
14-10-2026
Algoquant Fintech Limited has subscribed to 52,500 equity shares of AQ Capital Services Private Limited (AQCSPL), its 75%-held subsidiary, via a rights issue at ₹100 per share (₹10 face value plus ₹90 premium), for a total consideration of ₹52,50,000 (₹52.5 Lakh), paid in cash. The investment does not change the parent's 75% shareholding, and AQCSPL, which has not yet commenced operations and generated nil turnover, remains a subsidiary. The filing is a capital infusion into a pre-operational subsidiary rather than a new acquisition of an external business.
- · AQCSPL was incorporated on November 27, 2024 and is still awaiting SEBI registration to operate as a Registrar and Transfer Agent.
- · AQCSPL reported nil turnover for FY ended March 31, 2026, and nil turnover across the last three financial years since operations have not commenced.
- · The transaction is disclosed as a related party transaction on an arm's length basis, with no promoter or group company interest beyond Algoquant's holding.
- · Proceeds of the rights issue will fund SEBI registration costs, other costs, and running costs of AQCSPL.
- · No governmental or regulatory approvals are required for this investment.
14-10-2026
Brooks Laboratories Limited's Board approved a Scheme of Arrangement under Sections 230-232 of the Companies Act, 2013 to demerge its Manufacturing Business (Baddi facility, associated exports, loan-licensing, and P2P contract manufacturing with distribution channels) into wholly owned subsidiary Abridge Speciality Limited on a going-concern basis. The demerged undertaking generated Rs. 8,287.26 lakhs, about 96.66% of FY2025-26 turnover, so the retained trading business is comparatively small. The scheme is subject to SEBI, stock exchange, and NCLT approvals, with listing expected in about 16 months, and carries execution risk and no assurance on timing or benefits.
- · Share Entitlement Ratio is 1:1; 100 existing Brooks shares yield 100 new Abridge shares
- · Upon effectiveness, Abridge Speciality will be renamed Brooks Laboratories Limited and the existing company renamed Xuri Lifesciences Limited (or other name approved by RoC)
- · Existing 10,000 shares of Abridge held by Brooks will be cancelled upon allotment
- · Promoter/Promoter Group holds 100% of Abridge pre-scheme and will hold 52.62% post-scheme
- · Abridge is unlisted and proposes listing on BSE and NSE, subject to approvals
- · The scheme involves no cash consideration and no compromise with creditors
- · Board meeting ran from 4:00 PM to 5:30 PM IST on October 14, 2026
14-10-2026
Turtlemint Fintech Solutions Ltd's Board approved an investment of up to ₹149,51,13,103.05 (approximately ₹1,495.11 Mn / ₹149.51 Cr) in its wholly owned subsidiary Turtlemint Insurance Broking Services Private Limited (TIB) via subscription to a rights issue of up to 8,41,715 equity shares at ₹1,776.27 per share. The infusion is intended to fund TIB's working capital, including lease payments, and is in line with the objects of the IPO; the Company's shareholding in TIB remains unchanged at 100%. Because this is an intra-group capital infusion, it is not an acquisition of a new entity and carries no change in control.
- · TIB is a Composite Insurance Broker regulated by IRDAI, incorporated October 24, 2013, operating only in India
- · The investment is cash consideration with no regulatory approvals required and no indicative completion period specified
- · Not a related party transaction under the Companies Act, 2013, though two Company executives sit on TIB's board
- · TIB net worth of ₹1,758.63 Mn as at March 31, 2026, and paid-up capital of ₹1,68,31,741 post infusion
- · Filing made under Regulation 30 read with SEBI Circular dated January 30, 2026
14-10-2026
Highway Infrastructure Limited's board approved (i) an increase in authorised share capital from Rs. 40 Cr to Rs. 50 Cr, (ii) a preferential issue of up to 1,00,00,000 warrants to Promoter and Promoter Group members at Rs. 49.82 each, aggregating up to Rs. 49,82,00,000 (Rs. 49.82 Cr), with 25% (Rs. 12.46) payable upfront, (iii) the acquisition of 51% of Indore Highway Real Estates Private Limited for approximately Rs. 38,98,695 (about Rs. 0.39 Cr), partly from related parties, and (iv) the draft notice of an Extra Ordinary General Meeting to seek shareholder approval. The target company reported nil turnover for FY 2024-25 and FY 2025-26, after Rs. 59,44,634 in FY 2023-24.
- · Warrant issue price of Rs. 49.82 implies Rs. 12.46 upfront (25%) and Rs. 37.36 on exercise (75%); the Relevant Date for pricing is 14 October 2026
- · Acquisition is treated as a Related Party Transaction, with sellers including relatives of Directors; one seller, Rachna Agrawal, is stated not to be a related party
- · Target company's stated paid-up capital (Rs. 5,00,000 comprising 50,000 shares of Rs. 10) is inconsistent with the 25,500 shares = 51% arithmetic, which implies about 50,000 total shares; this should be verified
- · Acquisition is stated to be within the Section 186 limit approved by shareholders; no specific governmental or regulatory approval identified as of the disclosure date
- · Warrants lapse after 18 months if unexercised, and the upfront amount paid is forfeited
14-10-2026
Bajaj Healthcare Limited disclosed that the Hon'ble NCLT Mumbai Bench, by order dated October 13, 2026, approved the acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis, to become a wholly owned subsidiary subject to implementation of the NCLT order terms. The order is effective from October 13, 2026 until further orders, and the company's trading window remains closed for designated persons per the September 23, 2026 disclosure. The filing does not disclose any transaction value, consideration, or financial figures.
- · Order dated October 13, 2026 by NCLT Mumbai Bench; company downloaded it from the NCLT website on October 13, 2026
- · Genrx Pharmaceuticals will become a Wholly Owned Subsidiary of Bajaj Healthcare, subject to implementation of NCLT order terms
- · Trading window for designated persons and immediate relatives remains closed, per the September 23, 2026 disclosure
- · No aberrations, non-compliances, penalties, or restrictions were identified by the authority
14-10-2026
Kronox Lab Sciences Limited's Board of Directors, at its meeting on October 14, 2026, approved the acquisition of a plant of about 5,000 sq. meters located in the Dahej Special Economic Zone from Axiom Chemicals Private Limited. The acquisition is an asset (plant) purchase rather than a share acquisition, is funded by internal accruals, and is expected to be completed within one month subject to regulatory approvals and definitive agreements.
- · Consideration is entirely cash, funded through internal accruals, with no shares acquired
- · Transaction is not a related party transaction; no promoter, promoter group, or group company has any interest in the seller
- · Completion is indicative within one month, subject to SEZ/Development Commissioner approval for transfer of unit/land lease rights and other approvals such as State Pollution Control Board and GIDC consent
- · Deal price is not disclosed in the filing; cost includes taxes, duties, stamp duty, and registration charges
- · Seller is not being acquired, and the target is a plant/asset located at Z/80, Dahej SEZ
14-10-2026
United Foodbrands Limited (formerly Barbeque-Nation Hospitality Limited, BSE: 543283 / NSE: UFBL) disclosed that its wholly owned Dubai-based subsidiary, Barbeque Nation MENA Holding Limited, incorporated a private limited company, UFBL UK Limited, in England and Wales, approved by the Registrar of Companies on October 13, 2026. UFBL UK Limited becomes a Step-Down Subsidiary of the listed company, with GBP 50,000 share capital (5,000 shares of GBP 10 each), fully held (100%) by the holding subsidiary, to set up and operate restaurant businesses across the United Kingdom. This is a routine expansion disclosure with no acquisition of an existing business and no reported negative or mixed financial performance.
- · Incorporation approved by the Registrar of Companies for England and Wales on October 13, 2026
- · Filing made under Regulation 30 read with Schedule III of SEBI Listing Regulations, 2015
- · Cash consideration used for subscription, not a share swap
- · Holding is 100% via a Dubai-domiciled wholly owned subsidiary, placing UFBL UK Limited at step-down level
14-10-2026
Minda Corporation Limited has executed a Share Subscription Agreement with Avener Green Private Limited and Agganga Energy Private Limited, under which it will acquire a 26% equity stake in Agganga Private Limited, a renewable energy (solar photovoltaic power generation) company incorporated in 2025. The consideration is cash of up to Rs. 112.20 lacs, with completion expected in approximately 6 months, and the transaction is not a related party transaction. The filing is a routine Regulation 30 intimation with no reported revenue, as the target had nil turnover for FY2025-26.
- · Agganga Private Limited reported profit after tax of Rs. 0.03 lacs and nil turnover as of 31.03.2026
- · Agganga was incorporated in 2025 with its registered office in Gurgaon, Haryana
- · Transaction is not a related party transaction and no promoter or promoter group interest is involved
- · No governmental or regulatory approvals are required for the acquisition
- · Expected completion timeline is approximately 6 months
14-10-2026
INDO-MIM Limited's Board of Directors, at its October 14, 2026 meeting, approved the re-appointment of three Non-Executive Independent Directors (Mrs. Rajni Anil Mishra, Mrs. Meera Shankar and Mrs. Sujitha Karnad) for five-year terms from March 30, 2027 to March 29, 2032, subject to member approval via Postal Ballot. The Board also approved a revised Insider Trading Policy and the incorporation of a wholly owned foreign subsidiary in Vietnam, with an overall investment of Rs. 45 Crore over five years.
- · Proposed Vietnam subsidiary is a single member LLC, 100% owned by INDO-MIM, with no share issuance by the entity
- · Vietnam subsidiary tentatively scheduled for incorporation on December 1, 2026, pending approvals from Vietnam Business Registration office and RBI for Overseas Direct Investment
- · Vietnam subsidiary's business covers manufacture, assembly, sale and export of electronics, prototypes and engineering components
- · Board meeting commenced at 5:30 PM IST and concluded at 6:50 PM IST
14-10-2026
Laurus Labs Limited has invested INR 1,078,000,000 (INR 107.8 Crore) to acquire 107,800,000 equity shares of KRKA Pharma Private Limited at a face value of INR 10 each through a rights issue. Following the investment, Laurus's total holding in KRKA stands at 262,150,000 equity shares, and its shareholding percentage remains unchanged at 49%. This filing is a follow-up to the company's intimation dated April 30, 2026.
- · The investment was made under Regulation 30 of the SEBI (LODR) Regulations, 2015, as a continuation of the April 30, 2026 intimation
- · KRKA is a joint venture between Laurus Labs Limited and KRKA d.d., Novo mesto, Slovenia
14-10-2026
GMR Airports Limited has incorporated GMR Aero Realty Limited (GARL) as a wholly owned subsidiary in India, subscribing to its Memorandum of Association with an initial share capital of INR 1 Crore. GARL was incorporated on October 13, 2026 and will undertake real estate, land development, and related opportunities; it has not yet commenced business operations. The filing states the transaction is not a related party transaction and required no governmental or regulatory approvals.
- · GARL was incorporated on October 13, 2026, one day before the filing date
- · The subscription amount is to be remitted within applicable statutory timelines
- · The transaction is not a related party transaction and no promoter or group company holds an interest beyond direct/indirect shareholding
- · GARL is yet to commence business operations
14-10-2026
Exhicon Events Media Solutions Limited disclosed that its subsidiary, United Helicharters Private Limited (UHPL), has entered into an Aircraft Sale and Purchase Agreement with Dhillon Aviation Private Limited to acquire one Bell 206 L4 (Long Ranger IV) helicopter (Serial No. 52315, Registration VT-ZIN). The helicopter will expand UHPL's fleet for charter operations, and completion is subject to the agreement terms and DGCA regulatory formalities. The filing does not disclose the purchase consideration or financial impact.
- · Helicopter Manufacturer's Serial No. 52315 and Registration Mark VT-ZIN
- · Helicopter is suited to aerial surveillance, patrol, monitoring, survey, executive transfers, corporate charters, and tourism flights
- · Transaction completion is subject to DGCA regulatory requirements
- · Purchase price and financing terms are not disclosed in the filing
14-10-2026
GE Power India Limited has received a certified copy of the order from the Hon'ble National Company Law Tribunal, Mumbai Bench, dated 01 October 2026, sanctioning a Scheme of Arrangement under Sections 230 to 232 of the Companies Act, 2013. The scheme demerges the company's Demerged Business (manufacture and supply of power boiler components, pressure vessels, piping and coal mills for thermal power plants at the Durgapur Facility) into JSW Energy Limited in exchange for 10 new equity shares of JSW Energy for every 139 equity shares held in GE Power India. The Effective Date and Record Date will be communicated later.
- · Appointed Date for transfer and vesting of the Demerged Undertaking is 01.07.2025
- · Board resolutions approving the scheme were passed on 18.09.2025; NCLT admitted the petition on 10.08.2026 and final hearing was held on 04.09.2026
- · Equity shareholder and unsecured creditor meetings were held on 20.07.2026 via video conferencing; secured creditor meeting was dispensed with for JSW Energy and preference/secured creditor meetings were not required for GE Power India
- · Joint Share Entitlement Ratio Report dated 18.09.2025 was issued by RBSA Valuation Advisors LLP and GT Valuation Advisors Private Limited; both auditors certified the accounting treatment under Section 133
- · Certified copy of the sanction order was received by GE Power India on 13 October 2026, and the company will announce the Effective Date and Record Date later
- · Stated rationale includes focus on services growth for GE Power India and entry into boiler pressure parts manufacturing, vertical integration, and capacity expansion for JSW Energy
14-10-2026
JSW Energy Limited has received a certified copy of the NCLT Mumbai Bench sanction order, dated 1 October 2026, approving the Scheme of Arrangement between GE Power India Limited (demerged company) and JSW Energy (resulting company) under Sections 230 to 232 of the Companies Act, 2013. The Company will announce the Effective Date and Record Date separately. This is a procedural intimation with no quantitative financial results disclosed.
- · NCLT Mumbai Bench sanction order dated 1 October 2026; certified copy received by the Company on 13 October 2026
- · Sanction order and scheme documents published at https://www.jswenergy.in/investors/scheme-of-arrangement
- · Effective Date and Record Date to be intimated to stock exchanges in due course
14-10-2026
Hindustan Oil Exploration Company Limited (HOEC) has executed a definitive agreement with its Dirok joint venture partners (Oil India Ltd. and Indian Oil Corporation Ltd.) to take over the operations and ownership of the Hollong Modular Gas Processing Plant (HMGPP) in the Dirok Gas and Condensate field in Assam from service provider Expro North Sea Limited (UK). Operations were taken over as of October 14, 2026, and all existing ENS employees at the plant transferred to HOEC employment from that date. The takeover is intended to enable capacity expansion to process volumes from three newly approved wells and future North Dirok and Greater Dirok additions, along with efficiency-enhancing plant modifications.
- · HOEC is the designated operator for the Dirok Gas Field under the Production Sharing Contract between the Government of India and the JV partners (OIL, IOCL and HOEC)
- · Filed under Regulation 30 of SEBI (LODR) Regulations, 2015 with NSE (stock code HINDOILEXP) and BSE (stock code 500186)
- · No transaction consideration or valuation was disclosed in the filing
14-10-2026
Maithan Alloys Limited disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015 that it acquired 780,000 equity shares (0.05% shareholding) of HFCL Limited through the stock exchange on 13 October 2026 for a total cost of Rs. 20.00 Crore, paid in cash. The company states the investment is for long-term/short-term investment benefits and that it does not intend to acquire control of HFCL's management. HFCL reported FY 2025-26 turnover of Rs. 4528 Crore and PAT of Rs. 253 Crore, up from Rs. 3795 Crore turnover in FY 2024-25 but below Rs. 4075 Crore in FY 2023-24.
- · Company became aware of acquisition particulars on 14 October 2026 at 09:14 AM; the trade occurred 13 October 2026 at 3:30 PM
- · Disclosure triggered by crossing a Regulation 30 threshold; no related party interest, arm's length transaction, and no governmental/regulatory approvals required
- · HFCL's FY 2025-26 turnover growth of 19.3% partly recovers the FY 2024-25 decline, but remains above the FY 2023-24 level by roughly 11%
- · HFCL's FY 2024-25 turnover declined 6.9% year-on-year
14-10-2026
DRC Systems India Limited's Board approved acquiring a 49.00% stake in Skizzle Technolabs India Private Limited for an aggregate consideration not exceeding Rs. 2,00,00,000 (Rs. 2 Crore), replacing the earlier plan for a fresh investment, with completion targeted on or before March 31, 2027. The Board also approved divesting its entire 49.18% stake in associate Inexture Solutions Limited for a consideration not exceeding Rs. 1.02 Crore, with completion expected within 60 days of the agreement, which is to be signed on or before October 26, 2026. Inexture's FY2026 turnover was Rs. 1,902.88 Lakh and net worth Rs. 195.17 Lakh, so the disposal consideration is modest relative to the associate's reported net worth.
- · Skizzle acquisition was changed from a fresh investment to an acquisition of an existing stake from current shareholder(s); post-acquisition Skizzle becomes an Associate Company.
- · Skizzle acquisition may be completed in one or more tranches, subject to due diligence, definitive documents and approvals; the timeline was revised from the earlier intimation dated May 18, 2026.
- · Neither the Skizzle acquisition nor the Inexture disposal is a Related Party Transaction; promoters and group companies have no interest.
- · Inexture buyers are individuals who do not belong to the promoter or promoter group.
- · Post-divestment, Inexture Solutions Limited will cease to be an Associate of the Company.
Get daily alerts with 10 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 18 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Sector Consolidation Regulatory Filings
October 12, 2026
India Sector Consolidation Regulatory Filings — October 12, 2026
October 10, 2026
India Sector Consolidation Regulatory Filings — October 10, 2026
October 09, 2026
India Sector Consolidation Regulatory Filings — October 09, 2026
October 08, 2026
India Sector Consolidation Regulatory Filings — October 08, 2026
🇮🇳 More from India
View all →October 15, 2026
India Upcoming Corporate Actions BSE NSE — October 15, 2026
India Upcoming Corporate Actions BSE NSE
October 15, 2026
India Quarterly Results BSE NSE Announcements — October 15, 2026
India Quarterly Results BSE NSE Announcements
October 15, 2026
India Pre-Market Regulatory Roundup — October 15, 2026
India Pre-Market Regulatory Roundup
October 15, 2026
India RBI Monetary Policy Repo Rate Decisions — October 15, 2026
India RBI Monetary Policy Repo Rate Decisions